Objective: To assess the efficacy and tolerability of dual combination of blood pressure (BP)-
lowering drugs as initial treatment for hypertension. Methods: MEDLINE, Embase …

Cardiovascular diseases (CVD) are the world's leading cause of death. High blood pressure
(BP) is the leading global risk factor for all‐cause preventable morbidity and mortality …

Importance Poorly controlled hypertension is a leading global public health problem
requiring new treatment strategies. Objective To assess whether a low-dose triple …

The goal of antihypertensive therapy is to abolish the risks associated with blood pressure
(BP) elevation without adversely affecting quality of life. Drug selection is based on efficacy …

Objective: Two antidepressant medication combinations were compared with selective
serotonin reuptake inhibitor monotherapy to determine whether either combination …

Summary Background Single-pill combinations (SPCs) of three low-dose antihypertensive
drugs can improve hypertension control but are not widely available. A key issue for any …

Editor's Note: The American Society of Hypertension is publishing a series of Position
Papers in their official journals throughout the 2008–2011 years. The following Position …

Background Guidelines for hypertension vary in their preference for initial combination
therapy or initial monotherapy, stratified by patient profile; therefore, we compared the …

BACKGROUND: Dry cough is a common, annoying adverse effect of all angiotensin-
converting enzyme (ACE) inhibitors. The present study was designed to compare the rate of …

The long-term outcome of first-line moderate-intensity statin with ezetimibe combination
therapy for secondary prevention after percutaneous coronary intervention in patients with …